BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Osborne CS, Overstreet AN, Rockey DC, Schreiner AD. Drug-Induced Liver Injury Caused by Kratom Use as an Alternative Pain Treatment Amid an Ongoing Opioid Epidemic. J Investig Med High Impact Case Rep 2019;7:2324709619826167. [PMID: 30791718 DOI: 10.1177/2324709619826167] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Leong Bin Abdullah MFI, Singh D. Assessment of Cardiovascular Functioning Among Regular Kratom (Mitragyna speciosa Korth) Users: A Case Series. Front Pharmacol 2021;12:723567. [PMID: 34504428 DOI: 10.3389/fphar.2021.723567] [Reference Citation Analysis]
2 Eastlack SC, Cornett EM, Kaye AD. Kratom-Pharmacology, Clinical Implications, and Outlook: A Comprehensive Review.Pain Ther. 2020;9:55-69. [PMID: 31994019 DOI: 10.1007/s40122-020-00151-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
3 Teschke R, Danan G. Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993-Mid 2020: A Comprehensive Analysis. Medicines (Basel) 2020;7:E62. [PMID: 33003400 DOI: 10.3390/medicines7100062] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
4 Aldyab M, Ells PF, Bui R, Chapman TD, Lee H. Kratom-Induced Cholestatic Liver Injury Mimicking Anti-Mitochondrial Antibody-Negative Primary Biliary Cholangitis: A Case Report and Review of Literature. Gastroenterology Res. 2019;12:211-215. [PMID: 31523332 DOI: 10.14740/gr1204] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
5 Teschke R, Xuan TD. Suspected herb induced liver injury by green tea extracts: Critical review and case analysis applying RUCAM for causality assessment.Japanese J Gastroenterol Hepatol. 2019;6:1-16. [DOI: 10.21037/tgh-20-149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Groff D, Stuckey H, Philpott C, Van Dyke E, Silvis M, Leong SL, Bone C. Kratom use disorder: a primer for primary care physicians. J Addict Dis 2021;:1-11. [PMID: 34281482 DOI: 10.1080/10550887.2021.1950263] [Reference Citation Analysis]
7 Vento AE, de Persis S, De Filippis S, Schifano F, Napoletano F, Corkery JM, Kotzalidis GD. Case Report: Treatment of Kratom Use Disorder With a Classical Tricyclic Antidepressant. Front Psychiatry 2021;12:640218. [PMID: 33868054 DOI: 10.3389/fpsyt.2021.640218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Alsarraf E, Myers J, Culbreth S, Fanikos J. Kratom from Head to Toe—Case Reviews of Adverse Events and Toxicities. Curr Emerg Hosp Med Rep 2019;7:141-68. [DOI: 10.1007/s40138-019-00194-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
9 Jensen AN, Truong QN, Jameson M, Nadal CN. Kratom-induced transaminitis with subsequent precipitated opioid withdrawal following naltrexone. Ment Health Clin 2021;11:220-4. [PMID: 34026398 DOI: 10.9740/mhc.2021.05.220] [Reference Citation Analysis]
10 Davidson C, Cao D, King T, Weiss ST, Wongvisavakorn S, Ratprasert N, Trakulsrichai S, Srisuma S. A comparative analysis of kratom exposure cases in Thailand and the United States from 2010-2017. Am J Drug Alcohol Abuse 2021;47:74-83. [PMID: 33232183 DOI: 10.1080/00952990.2020.1836185] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Lautenschlager F, Weiss M, Feuerer S, Wodarz N. [Kratom - a short review for pain medicine]. Schmerz 2021. [PMID: 34533652 DOI: 10.1007/s00482-021-00588-9] [Reference Citation Analysis]
12 Botejue M, Walia G, Shahin O, Sharma J, Zackria R. Kratom-Induced Liver Injury: A Case Series and Clinical Implications. Cureus 2021;13:e14679. [PMID: 34055525 DOI: 10.7759/cureus.14679] [Reference Citation Analysis]
13 Leong Bin Abdullah MFI, Singh D. The Adverse Cardiovascular Effects and Cardiotoxicity of Kratom (Mitragyna speciosa Korth.): A Comprehensive Review. Front Pharmacol 2021;12:726003. [PMID: 34646135 DOI: 10.3389/fphar.2021.726003] [Reference Citation Analysis]
14 Metastasio A, Prevete E, Singh D, Grundmann O, Prozialeck WC, Veltri C, Bersani G, Corazza O. Can Kratom (Mitragyna speciosa) Alleviate COVID-19 Pain? A Case Study. Front Psychiatry 2020;11:594816. [PMID: 33329145 DOI: 10.3389/fpsyt.2020.594816] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
15 Leong Bin Abdullah MFI, Tan KL, Mohd Isa S, Yusoff NS, Chear NJY, Singh D. Lipid profile of regular kratom (Mitragyna speciosa Korth.) users in the community setting. PLoS One 2020;15:e0234639. [PMID: 32525924 DOI: 10.1371/journal.pone.0234639] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]